- Histogen press release (NASDAQ:HSTO): Q2 GAAP EPS of -$1.55.
- Cash and cash equivalents as of June 30, 2022 were $12.6M which excludes gross proceeds of approximately $5M from the private placement financing closed in July 2022.
- Stock -5% AH.
Histogen GAAP EPS of -$1.55
Recommended For You
More Trending News
About HSTO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
HSTO | - | - |
Histogen Inc. |